abilify maintena 300 mg
lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 300 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
abilify maintena 400 mg
lundbeck israel ltd. - aripiprazole as monohydrate - powder and solvent for prolonged-release suspension for injection - aripiprazole as monohydrate 400 mg/vial - aripiprazole - abilify maintena is indicated for maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole.
rexulti 0.5 mg
lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 0.5 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
rexulti 1 mg
lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 1 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
rexulti 2 mg
lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 2 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
rexulti 3 mg
lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 3 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
rexulti 4 mg
lundbeck israel ltd. - brexpiprazole - film coated tablets - brexpiprazole 4 mg - brexpiprazole - rexulti is indicated for:- as adjunctive therapy to antidepressants for the treatment of major depressive disorder (mdd) in adults- for treatment of schizophrenia in adults and pediatric patients ages 13 years and older.
vyepti
lundbeck israel ltd. - eptinezumab - concentrate for solution for infusion - eptinezumab 100 mg / 1 ml - eptinezumab - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.
selincro
h. lundbeck a/s - nalmefene hydrochloride dihydrate - alcohol-related disorders - drugs used in alcohol dependence - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking-risk level (see section 5.1), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drinking-risk level two weeks after initial assessment.
cipramil 20mg tablets
lundbeck ltd - citalopram hydrobromide - oral tablet - 20mg